Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia

ATM and TP53 mutations are associated with poor prognosis in chronic lymphocytic leukaemia (CLL). Here the authors generate mouse models of Tp53- and Atm-defective CLL mimicking the high-risk form of human disease and show that Atm-deficient CLL is sensitive to PARP1 inhibition.

Guardado en:
Detalles Bibliográficos
Autores principales: Gero Knittel, Tim Rehkämper, Darya Korovkina, Paul Liedgens, Christian Fritz, Alessandro Torgovnick, Yussor Al-Baldawi, Mona Al-Maarri, Yupeng Cun, Oleg Fedorchenko, Arina Riabinska, Filippo Beleggia, Phuong-Hien Nguyen, F. Thomas Wunderlich, Monika Ortmann, Manuel Montesinos-Rongen, Eugen Tausch, Stephan Stilgenbauer, Lukas P. Frenzel, Marco Herling, Carmen Herling, Jasmin Bahlo, Michael Hallek, Martin Peifer, Reinhard Buettner, Thorsten Persigehl, H. Christian Reinhardt
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Q
Acceso en línea:https://doaj.org/article/93c8b6674f2b4c01a38589c9951b35af
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:93c8b6674f2b4c01a38589c9951b35af
record_format dspace
spelling oai:doaj.org-article:93c8b6674f2b4c01a38589c9951b35af2021-12-02T13:24:23ZTwo mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia10.1038/s41467-017-00210-62041-1723https://doaj.org/article/93c8b6674f2b4c01a38589c9951b35af2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00210-6https://doaj.org/toc/2041-1723ATM and TP53 mutations are associated with poor prognosis in chronic lymphocytic leukaemia (CLL). Here the authors generate mouse models of Tp53- and Atm-defective CLL mimicking the high-risk form of human disease and show that Atm-deficient CLL is sensitive to PARP1 inhibition.Gero KnittelTim RehkämperDarya KorovkinaPaul LiedgensChristian FritzAlessandro TorgovnickYussor Al-BaldawiMona Al-MaarriYupeng CunOleg FedorchenkoArina RiabinskaFilippo BeleggiaPhuong-Hien NguyenF. Thomas WunderlichMonika OrtmannManuel Montesinos-RongenEugen TauschStephan StilgenbauerLukas P. FrenzelMarco HerlingCarmen HerlingJasmin BahloMichael HallekMartin PeiferReinhard BuettnerThorsten PersigehlH. Christian ReinhardtNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Gero Knittel
Tim Rehkämper
Darya Korovkina
Paul Liedgens
Christian Fritz
Alessandro Torgovnick
Yussor Al-Baldawi
Mona Al-Maarri
Yupeng Cun
Oleg Fedorchenko
Arina Riabinska
Filippo Beleggia
Phuong-Hien Nguyen
F. Thomas Wunderlich
Monika Ortmann
Manuel Montesinos-Rongen
Eugen Tausch
Stephan Stilgenbauer
Lukas P. Frenzel
Marco Herling
Carmen Herling
Jasmin Bahlo
Michael Hallek
Martin Peifer
Reinhard Buettner
Thorsten Persigehl
H. Christian Reinhardt
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
description ATM and TP53 mutations are associated with poor prognosis in chronic lymphocytic leukaemia (CLL). Here the authors generate mouse models of Tp53- and Atm-defective CLL mimicking the high-risk form of human disease and show that Atm-deficient CLL is sensitive to PARP1 inhibition.
format article
author Gero Knittel
Tim Rehkämper
Darya Korovkina
Paul Liedgens
Christian Fritz
Alessandro Torgovnick
Yussor Al-Baldawi
Mona Al-Maarri
Yupeng Cun
Oleg Fedorchenko
Arina Riabinska
Filippo Beleggia
Phuong-Hien Nguyen
F. Thomas Wunderlich
Monika Ortmann
Manuel Montesinos-Rongen
Eugen Tausch
Stephan Stilgenbauer
Lukas P. Frenzel
Marco Herling
Carmen Herling
Jasmin Bahlo
Michael Hallek
Martin Peifer
Reinhard Buettner
Thorsten Persigehl
H. Christian Reinhardt
author_facet Gero Knittel
Tim Rehkämper
Darya Korovkina
Paul Liedgens
Christian Fritz
Alessandro Torgovnick
Yussor Al-Baldawi
Mona Al-Maarri
Yupeng Cun
Oleg Fedorchenko
Arina Riabinska
Filippo Beleggia
Phuong-Hien Nguyen
F. Thomas Wunderlich
Monika Ortmann
Manuel Montesinos-Rongen
Eugen Tausch
Stephan Stilgenbauer
Lukas P. Frenzel
Marco Herling
Carmen Herling
Jasmin Bahlo
Michael Hallek
Martin Peifer
Reinhard Buettner
Thorsten Persigehl
H. Christian Reinhardt
author_sort Gero Knittel
title Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
title_short Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
title_full Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
title_fullStr Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
title_full_unstemmed Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia
title_sort two mouse models reveal an actionable parp1 dependence in aggressive chronic lymphocytic leukemia
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/93c8b6674f2b4c01a38589c9951b35af
work_keys_str_mv AT geroknittel twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT timrehkamper twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT daryakorovkina twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT paulliedgens twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT christianfritz twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT alessandrotorgovnick twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT yussoralbaldawi twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT monaalmaarri twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT yupengcun twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT olegfedorchenko twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT arinariabinska twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT filippobeleggia twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT phuonghiennguyen twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT fthomaswunderlich twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT monikaortmann twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT manuelmontesinosrongen twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT eugentausch twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT stephanstilgenbauer twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT lukaspfrenzel twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT marcoherling twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT carmenherling twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT jasminbahlo twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT michaelhallek twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT martinpeifer twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT reinhardbuettner twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT thorstenpersigehl twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
AT hchristianreinhardt twomousemodelsrevealanactionableparp1dependenceinaggressivechroniclymphocyticleukemia
_version_ 1718393107474546688